News
06-12-2022, 10:13 PM
Probiotic bacteria may enhance anti-cancer activities of the breast cancer drug tamoxifen and other endocrine-targeted therapies, which could help reduce the risk of estrogen receptive positive (ER+) breast cancer, suggests a new study presented Monday at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga.
More... (https://www.news-medical.net/news/20220613/Probiotic-bacteria-may-enhance-anti-cancer-activities-of-tamoxifen-to-reduce-ER2b-breast-cancer-risk.aspx)
More... (https://www.news-medical.net/news/20220613/Probiotic-bacteria-may-enhance-anti-cancer-activities-of-tamoxifen-to-reduce-ER2b-breast-cancer-risk.aspx)